3D Printing via Melt Extrusion Deposition Facilitates the Use of Extended-Release Profiles in Preclinical Research and Development

IVIVC公司 体内 药代动力学 挤压 剂型 药品 生物利用度 生物医学工程 溶解度 化学 药理学 溶解试验 材料科学 医学 生物制药分类系统 冶金 有机化学 生物技术 生物
作者
Miao Jin,Xianghao Zuo,Simone M. Blattner,Sandra Frankenreiter,Markus Metzger,Jingyu Lu,Takuya Kikuchi,Katsuyoshi Fujimoto,Atsushi Sakurai,Gang Wang,Achim Grube,Georg Boeck,Jun Lu
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
标识
DOI:10.1021/acs.molpharmaceut.5c00413
摘要

Traditional methods for developing modified-release (MR) formulations involve numerous iterations and large quantities of drug substances, which pose considerable challenges in exploration settings. Given the growing necessity for modified-release (MR) formulations in the pharmaceutical industry, particularly during the preclinical research and development phase, modified-release strategies may serve as attractive alternatives to discontinuing clinical development and could mitigate the costs and time associated with identifying new drug candidates. This study specifically explores the application of melt extrusion deposition (MED) 3D printing technology as a rapid prototyping platform for creating extended-release (ER) oral dosage forms tailored for the preclinical phase. Using the model compound BI 894416, the study demonstrated that MED 3D printing enables precise control over drug release profiles through both structural and compositional designs. The physicochemical analysis conducted during the 3D printing process revealed no degradation or compatibility issues. In vivo pharmacokinetic (PK) studies in rats and dogs validated the extended-release (ER) performance of BI 894416, with tmax values of 2-4 h in rats and 5 h in dogs. The ER tablets achieved prolonged plasma exposure and reduced peak-to-trough fluctuations compared to those of immediate-release (IR) formulations (ER: 144 versus IR: 929 in dogs). A Level A in vitro-in vivo correlation (IVIVC) was established, demonstrating strong alignment between in vitro dissolution and in vivo absorption up to 4 h, with a minor lag time observed. These results further confirmed the likely absorption of BI 894416 in the upper gastrointestinal (GI) tract and the potentially ascending colon. These findings highlight the potential of MED 3D printing to streamline the development of MR formulations in preclinical settings, offering a flexible, efficient, and material-sparing alternative to conventional approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类应助whisper采纳,获得10
刚刚
杨洋完成签到 ,获得积分10
刚刚
刚刚
ding应助wd采纳,获得10
1秒前
甜美的松鼠完成签到 ,获得积分10
1秒前
1秒前
科研通AI6.4应助老马采纳,获得10
1秒前
1秒前
2秒前
2秒前
一步之遥发布了新的文献求助10
2秒前
e麓绝尘完成签到 ,获得积分0
2秒前
e麓绝尘完成签到 ,获得积分0
2秒前
dongdongliu完成签到,获得积分10
3秒前
3秒前
ZeKaWang发布了新的文献求助200
3秒前
小猪驳回了今后应助
4秒前
迷人葶完成签到,获得积分20
4秒前
LG关闭了LG文献求助
4秒前
邓焕然完成签到,获得积分10
4秒前
purejun发布了新的文献求助10
4秒前
朴素的不乐完成签到 ,获得积分10
5秒前
bkagyin应助C14H10采纳,获得10
5秒前
许诺发布了新的文献求助10
5秒前
爱吃的肥虾完成签到,获得积分10
5秒前
5秒前
5秒前
苏苏完成签到,获得积分10
5秒前
Owen应助热热采纳,获得10
5秒前
涂上小张完成签到,获得积分10
5秒前
希望天下0贩的0应助fanggg采纳,获得10
6秒前
6秒前
ZBY完成签到,获得积分10
6秒前
初见发布了新的文献求助10
6秒前
漂亮的老四完成签到,获得积分20
7秒前
丰富的小甜瓜完成签到,获得积分10
7秒前
小蘑菇应助CHA采纳,获得10
7秒前
7秒前
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Organometallic Chemistry of the Transition Metals 800
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6437245
求助须知:如何正确求助?哪些是违规求助? 8251654
关于积分的说明 17555845
捐赠科研通 5495538
什么是DOI,文献DOI怎么找? 2898406
邀请新用户注册赠送积分活动 1875220
关于科研通互助平台的介绍 1716268